ML10302 is a potent 5-HT4 receptor agonist (Ki = 1.07 nM) that stimulates gastrointestinal motility via cholinergic pathways; it induces significant prokinetic effects in the small intestine and colon through activation of cholinergic pathways; it also shows potential for the study of neurological disorders.